Publications of T. C. Wetter
All genres
Journal Article (90)
41.
Journal Article
38 (5), p. 284 - 284 (2005)
Functional neuroanatomical correlates of spectral EEG power during NREM sleep. Pharmacopsychiatry 42.
Journal Article
38 (5), p. 285 - 285 (2005)
Periodic leg movements and neuroleptic-induced parkinsonism in patients with schizophrenia. Pharmacopsychiatry 43.
Journal Article
16 (8), pp. 853 - 857 (2005)
Rapid eye movement-related brain activation in human sleep: a functional magnetic resonance imaging study. NeuroReport 44.
Journal Article
10 (3), pp. 537 - 552 (2005)
Emerging drugs for restless legs syndrome. Expert Opinion on Emerging Drugs 45.
Journal Article
6 (15), pp. 2655 - 2666 (2005)
Dopamine agonists for the treatment of restless legs syndrome. Expert Opinion on Pharmacotherapy 46.
Journal Article
19 (2), p. 125 - 125 (2005)
PGO-like activity in human REM sleep detected by FMR1. Journal of Psychophysiology 47.
Journal Article
19 (10), pp. 1158 - 1162 (2004)
Presynaptic dopaminergic function in patients with restless legs syndrome: Are there common features with early Parkinson's disease? Movement Disorders 48.
Journal Article
5 (4), pp. 401 - 406 (2004)
Functional neuroimaging studies in restless legs syndrome. Sleep Medicine 49.
Journal Article
62 (8), pp. 1391 - 1397 (2004)
Efficacy of pergolide in treatment of restless legs syndrome - The PEARLS Study. Neurology 50.
Journal Article
14 (Suppl. 1), p. S49 - S49 (2004)
Brain networks in sleep as revealed by combined EEG and fMRI. European Neuropsychopharmacology 51.
Journal Article
20, pp. 566 - 574 (2004)
Functional MRI during sleep: BOLD signal decreases and their electrophysiological correlates. European Journal of Neuroscience 52.
Journal Article
18 (11), p. 756 - 756 (2004)
Ropinirole - A viewpoint by Thomas C. Wetter. CNS Drugs 53.
Journal Article
5 (1), pp. 93 - 95 (2004)
Association between polymorphism within the promoter region of the serotonin transporter gene and treatment response in depression - further evidence but still controversial issues. Sleep Medicine 54.
Journal Article
28 (10), pp. 1866 - 1870 (2003)
The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson's disease. Neuropsychopharmacology 55.
Journal Article
18 (10), pp. 1184 - 1189 (2003)
One-year treatment with standard and sustained-release levodopa: Appropriate long-term treatment of restless legs syndrome? Movement Disorders 56.
Journal Article
4 (10), pp. 1727 - 1738 (2003)
Current treatment options for restless legs syndrome. Expert Opinion on Pharmacotherapy 57.
Journal Article
36 (5), p. 218 - 218 (2003)
Thalamo-cortical synchronization across the sleep-wake cycle: A combined fMRI/EEG study. Pharmacopsychiatry 58.
Journal Article
36 (5), p. 271 - 271 (2003)
Different brain reactivity during phasic and tonic REM sleep: A simultaneous fMRI and EEG study. Pharmacopsychiatry 59.
Journal Article
36 (5), p. 272 - 272 (2003)
Processing of acoustic stimuli during NREM sleep: Results from a simultaneous fMRI and EEG study. Pharmacopsychiatry 60.
Journal Article
26, p. A61 - A61 (2003)
Evidence for different brain reactivity to external stimuli during phasic and tonic REM sleep: A simultaneous FMRI and EEG study. Sleep